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Abstract
Background: Levels of byproducts that result from the disinfection of drinking water vary within a water
distribution system. This prompted us to question whether the risk for rectal cancer also varies, depending upon
one's long term geographic location within the system. Such a geographic distribution in rectal cancer risk would
follow naturally from an association between level of byproduct and rectal cancer risk. We assess the effects of
estimated geographic variability in exposure to some of the components of the trihalomethane group of
disinfectant byproducts (DBPs) on the odds ratios and probabilities for rectal cancer in white males in a case
control study of 128 cases and 253 controls, conducted in Monroe County, Western New York State, U.S.A. The
study was designed around health data initially collected at the University at Buffalo (Department of Social and
Preventative Medicine) as part of the Upstate New York Diet Study, and trihalomethane (THM) data collected
from a separate independent study of THMs conducted by Monroe County Department of Health. Case
participants were chosen from hospital pathology records. The controls are disease-free white males between
35–90 years old, living in Monroe County, and chosen from control groups for studies from cancer of five other
(unrelated) sites. Using a combination of case control methodology and spatial analysis, the spatial patterns of
THMs and individual measures of tap water consumption provide estimates of the effects of ingestion of specific
amounts of some DBPs on rectal cancer risk. Trihalomethane (THM) data were used to spatially interpolate levels
at the taps of cases and controls, and odds ratios were estimated using logistic regression to assess the effects of
estimated THM exposure dose on cancer risk, adjusting for alcohol, dietary beta carotene intake, tap water
intake, and total caloric intake.
Results: Trihalomethane levels varied spatially within the county; although risk for rectal cancer did not increase
with total level of trihalomethanes, increasing levels of the component bromoform (measured in ug/day) did
correspond with an increase in odds ratios (OR = 1.85; 95% CI = 1.25 – 2.74) for rectal cancer. The highest
quartiles of estimated consumption of bromoform (1.69–15.43 ug/day) led to increased risk for rectal cancer (OR
= 2.32; 95% CI = 1.22–4.39). Two other THMs were marginally associated with an increase in risk –
chlorodibromomethane (OR = 1.78, 95% CI = 1.00–3.19) and bromodichloromethane (OR = 1.15; 95% CI =
1.00–1.32).
Conclusion: Levels of THMs in the water distribution system exhibited spatial variation that was partially due to
variation in water age. We also observed a geographic pattern of increased risk of rectal cancer in areas with the
highest levels of bromoform in the county.
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Background
At a global scale there are geographic differences in the
prevalence of rectal cancer, and the highest rates generally
occur in economically developed areas (e.g., Australia,
Japan, New Zealand, and North America) compared with
less developed areas (e.g., Africa and China). This is most
often explained by environmental factors related to diet
[1]. There are also geographic disparities within the
United States; for example, Devesa et al. [2] summarized
geographic patterns of urinary bladder and rectal cancers
in the U.S. for the period 1950–94 and noted that
throughout the period, high rates clustered in the north-
eastern United States. Other potential risk factors for rec-
tal cancer include tobacco consumption [3,4], alcohol
consumption [5,6], genetic disposition [7,8], occupa-
tional exposures [9,10], diet [5,11-13], and disinfectant
by-products (DBPs), the focus of the present study.
DBPs in water supplies are formed from the interaction of
organic material in raw water and an introduced disinfect-
ant. DBPs are particularly problematic in surface water
supplies since they generally contain the largest amount
of organic material [14]. Early work, published soon after
their discovery, found that some of the byproducts of the
disinfection process are carcinogenic [15-18]; however,
the carcinogenic potential of many DBPs remains
unknown [19,20]. The geographic component of risk
stems from the well-established association between DBP
formation and pipe retention time [21-24]. If other post-
disinfection variables are held constant (pipe condition,
temperature etc.), DBP levels generally increase with
increasing post-disinfection time (often related strongly
to distance), measured from the fresh water treatment
plant. Although the relationship between retention/reac-
tion times and DBP formation is a complex one with
many possible covariates, in an open pressure water distri-
bution system (one in which greater distance from the
treatment plant implies longer pipe retention times) we
would expect the highest levels of DBPs to be at those
areas at the far reaches of the network. This possible space-
time relationship prompted us to examine if there were
geographic disparities in the probability of developing
rectal cancer within a single distribution system. Although
much of the focus concerning the carcinogenic potential
of DBPs has centered on the urinary bladder [25-27],
some studies have demonstrated a relationship between
DBPs and cancers of the colon and/or rectum [28-31],
kidney [32], and possible adverse effects on birth out-
comes [33-35].
Although mouse models generally support carcinogenic-
ity of some THMs in the intestine, results of studies in
human populations are mixed. Evidence in support of car-
cinogenicity of exposure to disinfected water in the course
of everyday activities in human populations [27,29,36-
40] is offset by equally compelling studies [30,41,42] sug-
gesting no significant relationship. In an analysis of six
rectal cancer studies conducted prior to 1992, Morris [43]
reported a pooled risk of 1.38 for exposure to DBPs. In an
earlier study conducted in the county adjacent to where
the present study was conducted, Carlo [44] found no
association between areas of increased THM levels and
rectal cancer. Most similar to the present study, King and
Marrett [30] accounted for individual THM intake and
found that risk increased for colon cancer as years of expo-
sure to THM increased, but found no such relationship for
rectal cancer. Results of the present study suggest that lack
of consistent statistical evidence of rectal cancer risk may
be at least partially the result of not differentiating expo-
sure to various components of the THM mixture. Rodent
studies [45,46] suggest the brominated compounds to be
most carcinogenic in the intestine; however, the bromi-
nated compounds are only a component (generally a less
volatile component than many other THM compounds,
perhaps making it more likely to be consumed in drinking
water vs. other routes of exposure) of the total trihalom-
ethanes often used to test exposure-based risk in humans.
A 1985 study [47] indicates assessment of relevant indi-
vidual exposure to organics in drinking water a "thorny
barrier to progress" in assessing the risk associated with
development of cancer in the digestive tract, and this issue
continues to be a challenge to assessing DBPs and cancer
risk. We have attempted in the present study to provide
some refinement of exposure measurement from previous
studies of drinking water and cancer by differentiating and
assessing some individual trihalomethane compounds;
however, case sample size is limited, and assumptions
have been made that also reduce the power of the present
study as well.
Methods
Study design and subjects
The study was designed around case control data initially
collected at the University at Buffalo (Department of
Social and Preventative Medicine) as part of the Upstate
New York Diet Study. Trihalomethane data for our study
were supplied by Monroe County Water Authority
(MCWA) and the Monroe County Health Department,
and were generated from work unrelated to the Diet
Study. For the present study, all 128 case participants
(originally chosen from hospital pathology records) from
Monroe County were selected as a subset from the three-
county Diet Study. We confined the study to this area
because of the availability of THM data. Controls (253)
are disease-free white males between 35–90 years old, liv-
ing in Monroe County, and chosen from control groups
for studies from cancer of five other sites: oral cavity,
esophagus, stomach, larynx, and lung. We were interested
in evaluating the effects of residential address on the levels
of trihalomethanes (THMs) at the tap, total daily tapInternational Journal of Health Geographics 2007, 6:18 http://www.ij-healthgeographics.com/content/6/1/18
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water consumption, and the specific amount of additive
exposure to trihalomethanes given by the effect of these
two variables of interest on the odds ratio that study par-
ticipants were cases or controls. Because we used a geo-
graphically-based exposure variable (THM levels), we
chose not to include any address-matched controls from
the initial rectal cancer study [5]. More detail on the
Upstate New York Diet Study, including case and control
selection, and dietary assessment methodology is given
elsewhere [5,48-50]. Distributions of covariates for cases
and controls were similar (Table 1).
The Upstate Diet Study sought to assess the association
between several cancer types and the following dietary fac-
tors: vitamins, dietary fat, fiber, protein, caloric intake,
and commonly consumed non-nutritive items such as
coffee and tea. Covariate data for both cases and controls
were collected via nurse interviewers during extensive 2.5
hour interviews conducted from April 1978 – April 1986
[5]. Dietary and other data (including current address and
occupation, residential and occupational history, water
source (current and historical), and health history) were
taken with a modified food frequency questionnaire,
including intake on 129 foods, alcohol, and all other fluid
consumption, marital status, and other background data
not pertinent to the current study. From these data, indi-
ces of energy, fiber, and 15 nutrients were calculated
according to published food guidelines [5]. Survey instru-
ments were identical for all cases and controls. Cases were
asked about their dietary habits one year prior to diagno-
sis and controls were asked about their usual dietary hab-
its for the year prior to interview.
Study area and drinking water treatment and distribution
The geographic study area is Monroe County, located in
Western New York State (USA) on the shore of Lake
Ontario. Population of the county is approximately
753,000, including one major city (Rochester, pop.
219,000). Both cases and controls within Monroe County
receive water from Hemlock Lake and Lake Ontario via
the City of Rochester water treatment and distribution sys-
tem, and/or the Monroe County Water Authority treat-
ment and distribution system, with MCWA serving the
majority of the population. Trihalomethane data pro-
vided by the Monroe County Health Department
(MCHD) were used in conjunction with case control data
to determine THM exposure. MCWA distributes about 60
million gallons of water per day to 163,000 retail and
650,000 wholesale customers. MCWA treatment system
uses granular activated carbon as a post-chlorination filter
and Cl+2 as a disinfectant (known to produce byproduct
THMs, haloacids, and haloacetonitriles [23]). Distribu-
tion takes place within 2500 miles of pipes, with system
retention times through this network ranging from 5–30
days or more, and average times of 5–7 days (source: per-
sonal communication with Dick Metzger, engineer at
MCWA).
THM data
MCHD initiated a study of trihalomethanes in the water
treatment and distribution systems in the county in 1998.
MCHD tested public water supplies seven to ten or more
times per year (through all four seasons) at approximately
65 sample sites within the county for the THMs bromo-
form, bromodichloromethane, chloroform, chlorodibro-
momethane. In addition, a measurement is made for
"Total 551", which is a composite measure that includes
12 DBPs, based upon EPA's method 551 for testing
organic compounds in drinking water [51]. Mean and
median values for all THM samples are given in Table 2.
Testing for Total 551 began in 1998 and continued until
2003; other THMs were sampled over a two or three-year
period from 2000 to 2003. Approximately 80% of the
sample locations for the THM study were located within
the MCWA area of service; the remainder were within the
City of Rochester water system. Exchange of water
between these two systems can occur during peak demand
times and often involves bulk water purchased from
MCWA and distributed by Rochester Water Authority.
GIS THM modelling
Addresses of THM sample collection sites were provided
by MCHD and were used together with residential
addresses from the case control study using GIS. Case con-
trol addresses allowed for determination of the location of
each study participant in the water distribution system in
relation to the water sample points.
Table 1: Background information (mean, standard deviation) for cases and controls
Cases (128) Controls (253)
Age(yrs) 64.3(± 9.0) 64.4(± 9.6)
Education (yrs) 12.1(± 3.0) 12.4(± 3.3)
Height(cm) 172.7(± 7.1) 173.7(± 7.3)
Weight(kg) 79.1(± 13.2) 79.2(± 12.1)
Daily tap water drinking volume (l) 1.9(± 0.9) 1.8(± 0.9)
Total yrs. Public water 56.3(± 17.3) 60.2(± 15.3)
% life at present water source 88(± 1.8) 91(± 1.1)International Journal of Health Geographics 2007, 6:18 http://www.ij-healthgeographics.com/content/6/1/18
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The THM study included a wide range of measured values
at each sample location that reflected seasonal variation.
We obtained data for four sample locations within the sys-
tem that have been sampled since 1986 (approximately a
twenty year period). These sample locations are indicated
in Figure 1 and correspond to the graph in Figure 2.
Although the graph of long term measured values for total
trihalomethanes (Figure 2) indicates substantial seasonal
variation, long term averages have not experienced sub-
stantial change.
From MCHD's THM data we calculated the mean value
for each sample point. The resulting values were then used
in kriging, a method of interpolation, to provide a surface
of THM values from which we were able to extract esti-
mates for THM levels at the locations of cases and controls
in the study. These were then used in conjunction with
data from the case control study to determine rectal cancer
risk from Total 551, and from each THM component for
which estimates were available. There was a strong geo-
graphic pattern of THM levels (Moran's I = 0.04–0.82)
that was linked to water age and distance from treatment
source [52]. We found a highly significant (p < 0.001)
Pearson correlation coefficient (.251) between water age
at sample sites and THM levels. Although the magnitude
of the coefficient is small, the large sample size allows
rejection of the null hypothesis that water age and THM
levels are unrelated.
Statistical analysis
We used an unconditional maximum likelihood logistic
model formulated using a hierarchical backward elimina-
tion approach. Choice of covariate inclusion and model
construction proceeded mindful of [5], a study that
focused on the relationship between dietary factors and
rectal cancer.
We tested a host of possible covariates in numerous com-
binations. These included sodium intake, education, age,
ethnic background, occupation, weight, BMI, dietary fiber
intake, present weight, weight (3,2, and 1 year) prior to
interview, total caloric intake, calories from fat, retinol
intake, tap water intake, age, education, water intake from
foods, pack years of cigarette smoking and other forms of
tobacco consumption, total monthly alcohol consump-
tion (all types, including beer, wine and hard liquor), and
beta carotene intake as determined by [5]. In our results,
which we present below, we have adjusted for consump-
tion of alcohol, beta carotene, and total calories. The other
covariates were either not significant or had incorrect
signs, and were therefore omitted from the model. For
example, fiber and beta carotene are highly correlated in
the data, leading to an incorrect sign for the fiber variable;
hence there was no need to include both in the final set of
logistic regression models.
In assessing the potential effects of THMs, we include in
each model the following three variables: (a) an estimate
of THMs at the location of the case or control, (b) an esti-
mate of tap water consumption, and (c) an interaction
variable based upon the product of the previous two; that
is, a composite exposure variable representing consump-
tion of THMs per day.
Quartiles were created for bromoform exposure based on
the total daily consumption of bromform calculated as
the product of total daily tap water consumption in liters
and the bromoform level (ug/l) estimates determined
from the kriging model. Beverages included in the total
tap water consumption variable included coffee, tea (hot
and iced), 75% of reconstituted frozen orange juice, all
other juices (made with tap water), and glasses of water
taken directly from the tap. Dietary sources of tap water
were divided further into beverages usually made with
boiled tap water, such as coffee and tea, and beverages
made with unheated tap water. Triahlomethane data pro-
vided by the Monroe County Health Department were
given in ug/l, and consumption data were expressed as
cups per day. To determine total ug/day trihalomethane
consumption, total daily tap water consumption data
(cups) were converted to liters, based on 8 ounces of fluid
per cup, and 33.814 ounces per liter. These consumption
data were then multiplied by THM estimates to determine
total consumption of ug of individual THMs per day.
Model formulation for estimation of odds ratios for 
individuals
To determine odds ratio estimates for "average" individu-
als residing at each location in the study (Figure 3), mean
values for covariates (monthly alcohol intake in ounces,
Table 2: Mean and median of sampled THM levels (ug/l)
Bromoform Bromodichloro-methane Chloroform Chlorodibromo-methane Total 551
Mean 1.30 8.72 19.75 4.11 35.07
Median 0.45 8.48 17.61 3.80 33.00International Journal of Health Geographics 2007, 6:18 http://www.ij-healthgeographics.com/content/6/1/18
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beta carotene intake, total caloric intake, and fiber) were
used in the following expression for the odds, together
with the location-specific THM estimate:
This yields an estimate of the odds that, at a specific loca-
tion, an individual with "average" characteristics on the
covariates, and exposure to the mean THM level at that
location, is a case. Given that the ratio of cases to controls
as 128/253, it is approximately twice as likely that choos-
ing randomly from the sample set would yield a control
vs. a case. Therefore to phrase the odds of being a case in
terms of the risk of rectal cancer, we divided the resulting
odds by 128/253. The resulting odds are mapped in Figure
3.
e xxT H M nn T H M ββ β β 01 1 ++ + + ...
Bromoform level estimates from kriging model, and locations of long term sample sites indicated in Figure 4 Figure 1
Bromoform level estimates from kriging model, and locations of long term sample sites indicated in Figure 4. 
Note that levels represent average annual values. The highest level measured for bromoform within a single sampling period 
was > 10.0 ug/l.International Journal of Health Geographics 2007, 6:18 http://www.ij-healthgeographics.com/content/6/1/18
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Results
Cases and controls were nearly identical in age, education,
height, weight, and tap water consumption (Table 1).
Controls had a slightly longer history using public water
sources than cases. Both cases (88%) and controls (91%)
spent the majority of their life consuming water at the
source indicated during sampling.
We first examined the effect of a measure of total THMs
(Total 551) on increased risk of rectal cancer. The results
in Table 3 show that, after adjusting for covariates, there is
no apparent significant effect of tap water consumption,
THM level, or THM intake
per day on the risk of rectal cancer. Note that increasing
consumption of alcohol and total calories increase risk,
while increased consumption of beta carotene decreases
risk. Tap water consumption by itself did not affect rectal
cancer risk.
We next examined individual THM components, to assess
whether they had effects on risk (Table 4). After adjusting
for covariates, both bromoform level at the location of the
case or control (OR 1.20; 95% CI 1.05–1.37), and bromo-
form consumption (OR 1.85; 95% CI 1.25–2.74) were
significantly associated with increased risk for rectal can-
cer (Table 4). Not only do high levels of bromoform at the
residential location lead to higher risk of rectal cancer, but
this effect is enhanced among those who drink relatively
higher amounts of tap water. Chlorodibromomethane
was also marginally significant (OR = 1.78, 95% CI =
1.00–3.19), as was bromodichlromethane (OR = 1.15;
95% CI = 1.00–1.32); these results are also shown in
Table 4. Chloroform was not significantly associated with
increased risk for rectal cancer.
Figure 3 shows the spatial variation in point estimates of
rectal cancer risk, resulting from the bromoform model
shown in Table 4. Geographic patterns of tap water con-
sumption (one component of consumption exposure,
which is estimated as a composite of bromoform concen-
trations and total tap water consumption) were not as
marked (Figure 4) as the geographic distributions of esti-
mated bromoform concentrations (Figure 1). Spatial
trends of bromoform estimates closely corresponded to
the geographic trend associated with OR's (Figure 3). This
suggests that, although both are important, bromoform
levels within the system likely had a greater effect on OR's
than the amount of tap water that study participants con-
sumed.
We also created quartiles based upon bromoform con-
sumption estimates and found that after controlling for
covariates, odds ratios were significantly increased in the
fourth quartile of exposure to bromoform (OR 2.32, 95%
CI : 1.22–4.39) (Table 5). The range of total daily con-
sumption of bromoform for those in the highest quartile
was quite wide (1.69 – 15.43 ug/l); however, upon closer
examination, most individuals (seventy-five percent) con-
sumed less than 5 ug/l per day, and only a small portion
(seven percent) consumed greater than 10 ug/l per day.
Discussion
This is one of the first studies to use GIS in the exposure
assessment to evaluate cancer risk associated with DBPs.
The study uses a combination of individual tap water con-
sumption data from a case control study, and geographic-
based exposure analysis of disinfectant byproducts and
finds increased risk for males exposed to the highest levels
of bromoform. The dose-response pattern found for bro-
moform (Table 5) strengthens the association. Chlorodi-
bromomethane and bromodichloromethane had
elevated point estimates and confidence intervals that
were marginally significant (OR = 1.78; 95% CI 1.00–
3.19, and OR = 1.15; 95% CI 1.00–1.32, respectively).
Chlorinated drinking water contains a large range of
byproducts produced during the disinfection process, and
although many remain unidentified (accounting for more
than fifty percent of the mass of total organic halides)
[20], some have been established as carcinogenic. Of the
brominated byproducts produced, bromodichlorometh-
ane, and bromoform have been shown to be carcinogenic
e XXT H M nn T H M ββ β β 01 1 ++ + + ( )
( ) ... ( ) ( ) ... ...
Historic (1986 – 2007) total trihalomethane levels at four  sample sites in Monroe County, sample sites shown in Figure  1 Figure 2
Historic (1986 – 2007) total trihalomethane levels at four 
sample sites in Monroe County, sample sites shown in Figure 
1.International Journal of Health Geographics 2007, 6:18 http://www.ij-healthgeographics.com/content/6/1/18
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in laboratory animals [45,46,53], and chlorine and chlo-
ramines were not [46]. Although colorectal cancer risk has
been linked with a variety of ecological based water stud-
ies [27-29], with the exception of rodent studies, we found
no strong previous evidence in the literature suggesting
and/or supporting a specific association of rectal cancer
risk with exposure to bromoform in humans. Studies of
risk associated with exposure to DBPs are often based on
indirect exposure assessments that rely on relatively large
scales of geographic classifications of DBPs [54], and clas-
sification of exposed and unexposed groups is often made
based on town, parish, or areas served by specific water
treatment systems [28,29,31,42,55].
We attempted to refine the exposure assessments to
improve upon previous studies, and to define a specific
Individual odds ratios for rectal cancer risk for exposure to the THM bromoform Figure 3
Individual odds ratios for rectal cancer risk for exposure to the THM bromoform. Note: Dependent variable deter-
mined as total daily ingestion of bromoform (ug/l) given as daily tap water intake (ug/l) and total bromoform contents of tap 
water (ug/l). Adjusted via assigning "average" values for covariatesInternational Journal of Health Geographics 2007, 6:18 http://www.ij-healthgeographics.com/content/6/1/18
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amount of DBP consumption that may lead to increased
risk. By determining exposure as a mixture of water use
patterns for individuals and a more specific estimate for
DBPs at the tap, our study builds upon previous work
[30,31,39] and attempts to examine risk from specific
THM components and thereby avoid grouping all THMs
together. In our refinement of the THM component of
risk, bromoform, bromodichloromethane, and chlorodi-
bromethane stood out as potentially important in the
development of rectal cancer. Weaknesses in the approach
we use to determine byproduct exposure estimates
include (a) a time lag between case control data collection
and DBP data collection, (b) the related concern that DBP
data were not collected during the most relevant period of
exposure, (c) consequences of residential mobility influ-
encing exposure, and (c) kriging has been used on a net-
work, despite being an interpolation method designed for
planar data. Despite these limitations, some refinement of
exposure in this hybrid study has been attained.
To assess the first two of these limitations, we plotted a
time series of THM maps within GIS. From these plots we
were able to determine that, at least during the time for
which THM data were available (1998–2003), levels
decreased slightly, and spatial distributions remained rel-
atively unchanged [52]. In addition, Moran's Index calcu-
lated for THM sample sites indicated spatial clustering of
values, with the greatest number of samples over 75 ug/l
(for Total 551) occurring in the first half (1998–2000) of
the sample period [52]. Moran's I did not change much
over the period, indicating little change in the spatial pat-
tern. In addition, Figure 2 indicates that, for the period
1986 to 2007, there is not a pronounced tendency for lev-
els to change substantially over time (aside from seasonal
variation). In addition, the lines in the figure, representing
individual sample sites, do not cross one another in a
clear and consistent manner, supporting the contention
that spatial variation has not changed substantially.
Cancer studies of DBPs represent a unique challenge that
often requires estimating past exposures without the sup-
port of relevant measurements [56]. Faced with this prob-
lem, many studies of drinking water and cancer base
exposure estimates on geographic residence, partitioning
space into areas that receive disinfected water and those
that do not. Case control studies such as the one presented
here, that attempt to determine the effects of exposures
that likely take a considerable amount of time to produce
an outcome, are subject to subtle or even large changes in
the lifestyle of study participants (such as tap water con-
sumption) that may occur over long time periods, and
may not be readily recalled or accounted for. The WNY
Diet Study data for cases and controls were collected over
the period from 1979–1985. Mean age of study partici-
pants during the time of data collection was approxi-
mately 64 years. On average, potential exposure to DBPs
started in the 1950's and continued until the time of inter-
view. Our assumptions are similar in some respect to
those in the original study that examined drinking water
and cancer [49]. These assumptions are that water intake
indicated during the case control interview is representa-
tive of water intake levels during a significant part of the
participant's life span, and that spatial-based estimates of
THM levels are reasonable representations of spatial pat-
terns of THM distributions in the past. Regardless of how
DBP exposure is determined, either by direct testing at the
tap (essentially a 'snapshot' of DBP levels), or some
attempt to model exposure based on historic and or cur-
rent DBP levels [26,30] such assumptions regarding the
spatial distributions of DBPs are required.
Residential mobility is unlikely to have had detrimental
effects on our analyses. Cases and controls spent a large
percentage of their lives at the water source indicated dur-
ing interviews (Table 1). This reflects the relatively low
mobility that characterizes the region.
Kriging DBP levels within a distribution system is a novel
and potentially more accurate means of determining
exposure in DBP cancer studies through spatial interpola-
tion. Future work will be aimed at using network distance
in place of planar distance in the spatial interpolation.
Table 3: The effects of THMs (Total 551) and covariates on risk of rectal cancer
Variable OR 95% Confidence Interval p
Alcohol (1000 oz./month) 1.64 (1.09 – 2.47) 0.018
Betacarotene (10,000 IU/month) 0.58 (0.43 – 0.78) <0.001
Total Calories (10,000/month) 1.18 (1.02–1.36) 0.022
Tap water (liters) 1.05 (0.67–1.84) 0.831
Total 551 estimate (ug/l) 1.01 (0.98–1.03) 0.518
Total 551 consumption (ug/day) 1.01 (0.99–1.03) 0.330International Journal of Health Geographics 2007, 6:18 http://www.ij-healthgeographics.com/content/6/1/18
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Although changes and reductions of some DBPs upon
boiling are possible [57], we found no difference between
hot water tap consumption and cold water tap consump-
tion on rectal cancer risks in our study; this may be due in
part to a sample size in the current study that may have
been too small to measure such an effect. It may also be
the case that bromoform is serving as a surrogate for expo-
sure to some of the most mutagenic brominated forms of
other DBPs such as MX that are not affected by volatiza-
tion such as BMX-1, BMX-2, BMX-3 (58, 59).
Some studies [60,61] indicate that the causal relationship
between rectal cancer and THMs remains an open ques-
tion; however, "evidence is somewhat stronger for rectal
cancer than colon cancer" [60]. Although many of the
myriad possibilities of exposure routes, some of which
have shown to significantly affect THM blood levels
[62,63] (e.g. dishwashing, showering, swimming), have
yet to be tested for their potential to influence risk, diges-
tive tract cancers are more likely to be influenced by direct
consumption than by inhalation or dermal routes. In
addition, bromoform was not found to increase in the
blood following certain daily activities [62].
Disinfectant byproducts in drinking water have garnered a
considerable amount of attention since their discovery in
1975. Although many byproducts are thought to have car-
cinogenic potential, much of the focus has been on the tri-
halomethane group. Despite numerous clinical and field
studies examining the effects on human health of DBP
exposure, no conclusive paper has emerged that suggests
what level of exposure might be acceptable. In the U.S.A,
for many contaminants the Environmental Protection
Agency establishes a health goal or maximum contami-
nant level (MCL). The goals are not necessarily legal limits
with which water systems must comply. It should be
noted that MCWA was well within compliance with fed-
eral standards for total trihalomethanes during the entire
sampling period. At no time during the five-year testing
period did the system exceed the previous (effective until
12/30/01) legal MCLs for total trihalomethanes of 0.10
mg/l2; the current standards for bromoform (0.08 ug/l2),
were marginally exceeded only a handful of times for all
samples.
It is certain that the present study has exposure misclassi-
fication, but we have no reason to believe that it is differ-
ential between cases and controls, and hence any
misclassification should bias risk estimates towards the
null. Nonetheless, we found elevated risk estimates for the
highest estimated levels of exposure to THMs. Our study
has the advantage of measures of individual intake of
drinking water, and estimated exposure to THMs based on
location of residence in the distribution system coupled
with a study population with a stable residential history.
Conclusion
A logistic regression model based on data for 128 cases of
rectal cancer and 253 controls in Monroe County, NY,
revealed increased risk for rectal cancer with increased lev-
els of particular DBPs. In particular we found that loca-
tions with a high level of bromoform in the water
Table 4: The effects of bromoform, chlorodibromethane, and bromodichloromethane on risk of rectal cancer.
Bromoform Chlorodibromo-methane Bromodichloro-methane Chloroform
OR 95% CI p OR 95% CI p OR 95%CI p OR 95%CI p
Alcohol (1000 oz./month) 1.77 (1.16 – 2.70) 0.008 1.65 (1.10–2.47) .005 1.68 (1.12–2.52) 0.012 1.63 (1.09 – 2.44) 0.018
Betacarotene (10,000 IU/month) 0.56 (0.41–0.76) <0.001 0.65 (0.50–0.84) 0.001 0.64 (0.50–0.84) 0.001 0.64 (0.49–0.83) <0.001
Total Calories (10,000/month) 1.22 (1.05–1.40) 0.005 1.27 (1.14–1.42) <0.001 1.26 (1.13–1.42) <0.001 1.27 (1.14–1.42) <0.001
Tap water (liters) 0.94 (0.73–1.20) 0.601 1.07 (0.45–2.59) 0.880 0.99 (0.83–1.16) 0.900 1.05 (0.52–2.12) 0.887
THM estimate (ug/l) 1.20 (1.05–1.35) 0.007 1.16 (0.85–1.58) 0.173 0.93 0.82–1.13) 0.465 1.00 (0.93–1.09) 0.777
THM consumption (ug/day) 1.85 (1.25–2.74) 0.002 1.78 (1.00–3.19) 0.052 1.15 (1.00–1.32) 0.047 1.00 (0.98–1.02) 0.908
"THM estimate" and "THM consumption" refer to the effects of individual THM components specified in each column.
Table 5: Quartiles of odds ratios1 of risk for rectal cancer for total daily ingestion (ug/day) from tap water of bromoform from tap 
water in Monroe County, New York State
Bromoform Quartile (ug/day) OR (95%CI) β p value
1 (Low) (0.90–0.64) ----- ----- -----
2 (0.65–0.97) 1.42 (0.73–2.74) 0.35 0.42
3 (0.98–1.68) 1.63 (0.85–2.69) 0.49 0.10
4 (High)(1.69–15.43) 2.32 (1.22–4.39) 0.84 0.01
1: abbreviations are as follows: OR, odds ratio; CI, confidence interval
2: exposure determined from consumption of tap water and estimated levels of bromoform (ug/l)
3: Results adjusted for covariates listed in Table 3
4: p-value for linear trend: 0.002International Journal of Health Geographics 2007, 6:18 http://www.ij-healthgeographics.com/content/6/1/18
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distribution system corresponded with an increase in the
odds ratio (OR = 1.85; 95% CI = 1.25 – 9.56) for rectal
cancer. In addition to bromoform level at a given loca-
tion, consumption of bromoform was also significant.
The highest quartiles of estimated consumption of bro-
moform (1.69–15.43 ug/day) led to increased risk for rec-
tal cancer (OR = 2.32; 95% CI = 1.22–4.39). Two other
THMs were marginally associated with a possible increase
in risk (chlorodibromomethane (OR = 1.78, 95% CI =
1.00–3.19) and bromodichloromethane (OR = 1.15; 95%
CI = 1.00–1.32)).
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